In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to various quality-of-life domains.

Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...

An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...

In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...

Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease with a heterogeneous clinical presentation, ranging from mild cutaneous manifestations to severe organ damage. One of ...

The total market size of systemic lupus erythematosus is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research of therapies such as nipocalimab (Johnson & ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...

It's long been known that money woes tend to worsen health outcomes in people with chronic diseases. The demographics of ...